Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
2026
Trading update
Apr 13, 2026
Retail sales fell 22% and EBITDA dropped, with refinancing providing stability.
Earnings, H1 FY2026
Dec 23, 2025
Retail sales fell 25% and EBITDA dropped, but debt reduction and new partnerships offer growth potential.
2025
Earnings, H2 FY2025
Annual
Sep 25, 2025
Retail sales fell 18% to £230.6m, with profit boosted by a South Asia JV and debt reduction.
Trading Update
May 8, 2025
Sales fell 18% amid Middle East headwinds, but net borrowings dropped and growth plans continue.
Earnings, H1 FY2025
Dec 2, 2024
New South Asian JV and refinancing de-leverage Mothercare amid ongoing Middle East challenges.
2024
Earnings, H2 FY2024
Annual
Oct 17, 2024
Adjusted EBITDA grew to £6.9m as debt refinancing and a South Asia JV improved financial stability.